These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 16105079)
1. Postprocedural drop in hematocrit versus contrast-induced nephropathy: eggs or chickens? Lai MY; Lin CC; Yang WC Kidney Int; 2005 Sep; 68(3):1371-2; author reply 1372. PubMed ID: 16105079 [No Abstract] [Full Text] [Related]
2. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Nikolsky E; Mehran R; Lasic Z; Mintz GS; Lansky AJ; Na Y; Pocock S; Negoita M; Moussa I; Stone GW; Moses JW; Leon MB; Dangas G Kidney Int; 2005 Feb; 67(2):706-13. PubMed ID: 15673320 [TBL] [Abstract][Full Text] [Related]
3. Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention. Marenzi G; De Metrio M; Rubino M; Lauri G; Cavallero A; Assanelli E; Grazi M; Moltrasio M; Marana I; Campodonico J; Discacciati A; Veglia F; Bartorelli AL Am Heart J; 2010 Dec; 160(6):1170-7. PubMed ID: 21146674 [TBL] [Abstract][Full Text] [Related]
5. Acute hyperglycemia: is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function? Raposeiras-Roubín S; Barreiro Pardal C; Ocaranza R; Cid B; González-Juanatey JR Am Heart J; 2011 Jul; 162(1):e7; author reply e9. PubMed ID: 21742082 [No Abstract] [Full Text] [Related]
13. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial. Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264 [TBL] [Abstract][Full Text] [Related]
14. Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty. Ricottini E; Giannone S; Melfi R; Nusca A; Mangiacapra F; Gallo P; Cocco N; Rinaldi R; Ussia GP; Grigioni F Coron Artery Dis; 2023 Aug; 34(5):372-373. PubMed ID: 37335222 [No Abstract] [Full Text] [Related]
15. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention. Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069 [TBL] [Abstract][Full Text] [Related]
16. Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention. Fu N; Li X; Yang S; Chen Y; Li Q; Jin D; Cong H Angiology; 2013 Apr; 64(3):188-94. PubMed ID: 23196639 [TBL] [Abstract][Full Text] [Related]
17. Prophylaxis against contrast-induced nephropathy. Oliveira DB Lancet; 1999 May; 353(9165):1638-9. PubMed ID: 10335780 [No Abstract] [Full Text] [Related]
18. Contrast loaded with N-acetylcysteine for coronary imaging during percutaneous coronary intervention: a new concept for renal and myocardial protection during percutaneous coronary intervention. Fischell TA JACC Cardiovasc Interv; 2009 Mar; 2(3):222-3. PubMed ID: 19463429 [No Abstract] [Full Text] [Related]